APOE and amyotrophic lateral sclerosis: Although there are no similar studies in APOE ε4 carriers, the volume of the hypothalamus is affected in presymptomatic mutation carriers for amyotrophic lateral sclerosis,47 and in prodromal Huntington's disease, up to 15 years before predicted clinical diagnosis.48